Lista de obras - Richard Brown - Dominio Público Uruguay

A Diverse Panel of Hepatitis C Virus Glycoproteins for Use in Vaccine Research Reveals Extremes of Monoclonal Antibody Neutralization Resistance.

artículo científico publicado en 2015

A case of hepatitis C virus transmission acquired through sharing a haemodialysis machine.

artículo científico publicado en 2010

A central hydrophobic E1 region controls the pH range of hepatitis C virus membrane fusion and susceptibility to fusion inhibitors

scientific article published on 13 February 2019

Acute hepatitis C virus infection: a dynamic-and challenging-concept.

artículo científico publicado en 2010

An alpaca nanobody inhibits hepatitis C virus entry and cell-to-cell transmission

artículo científico publicado en 2013

Analysis of serine codon conservation reveals diverse phenotypic constraints on hepatitis C virus glycoprotein evolution

artículo científico publicado en 2014

Cell entry, efficient RNA replication, and production of infectious hepatitis C virus progeny in mouse liver-derived cells.

artículo científico publicado en 2013

Characterization of hepatitis C virus intra- and intergenotypic chimeras reveals a role of the glycoproteins in virus envelopment

artículo científico publicado en 2013

Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33.

artículo científico publicado en 2006

Clinical course of infection and viral tissue tropism of hepatitis C virus-like nonprimate hepaciviruses in horses

artículo científico publicado en 2015

Determination of the human antibody response to the epitope defined by the hepatitis C virus-neutralizing monoclonal antibody AP33.

artículo científico publicado en 2007

Development of a high-throughput pyrosequencing assay for monitoring temporal evolution and resistance associated variant emergence in the Hepatitis C virus protease coding-region.

artículo científico publicado en 2014

Efficient acute and chronic infection of stem cell-derived hepatocytes by hepatitis C virus

artículo científico publicado en 2020

Evolutionary dynamics of hepatitis C virus envelope genes during chronic infection.

artículo científico publicado en 2005

Exacerbation of hepatitis E virus infection during anti-TNFα treatment

artículo científico publicado en 2016

Flunarizine prevents hepatitis C virus membrane fusion in a genotype-dependent manner by targeting the potential fusion peptide within E1.

artículo científico publicado en 2015

Functional and immunogenic characterization of diverse HCV glycoprotein E2 variants

artículo científico publicado en 2018

Genetic Diversity Underlying the Envelope Glycoproteins of Hepatitis C Virus: Structural and Functional Consequences and the Implications for Vaccine Design

artículo científico publicado en 2015

Hepacivirus NS3/4A Proteases Interfere with MAVS Signaling in both Their Cognate Animal Hosts and Humans: Implications for Zoonotic Transmission

artículo científico publicado en 2016

Hepatitis C Virus

scientific article published on 29 January 2019

Hepatitis C Virus Strain-Dependent Usage of Apolipoprotein E Modulates Assembly Efficiency and Specific Infectivity of Secreted Virions.

artículo científico publicado en 2017

Hepatitis C patient-derived glycoproteins exhibit marked differences in susceptibility to serum neutralizing antibodies: genetic subtype defines antigenic but not neutralization serotype.

artículo científico publicado en 2011

Hepatitis C virus envelope glycoprotein fitness defines virus population composition following transmission to a new host

artículo científico publicado en 2012

Hepatitis E Virus (HEV) ORF2 Antigen Levels Differentiate Between Acute and Chronic HEV Infection

artículo científico publicado en 2016

Identification of Conserved Residues in the E2 Envelope Glycoprotein of the Hepatitis C Virus That Are Critical for CD81 Binding

artículo científico publicado en 2006

Identification of Keratin 23 as a Hepatitis C Virus-Induced Host Factor in the Human Liver

scientific article published on 18 June 2019

Immune protection against reinfection with nonprimate hepacivirus.

artículo científico publicado en 2017

Immunization with a synthetic consensus hepatitis C virus E2 glycoprotein ectodomain elicits virus-neutralizing antibodies

artículo científico publicado en 2018

In vivo evidence for ribavirin-induced mutagenesis of the hepatitis E virus genome

artículo científico publicado en 2016

Incorporation of primary patient-derived glycoproteins into authentic infectious hepatitis C virus particles.

artículo científico publicado en 2014

Intercompartmental recombination of HIV-1 contributes to env intrahost diversity and modulates viral tropism and sensitivity to entry inhibitors

artículo científico publicado en 2011

Ion Channel Function and Cross-Species Determinants in Viral Assembly of Nonprimate Hepacivirus p7 ⬇️

artículo científico publicado en 2016

Liver-expressed Cd302 and Cr1l limit hepatitis C virus cross-species transmission to mice

artículo científico publicado en 2020

Mannan binding lectin-associated serine protease 1 is induced by hepatitis C virus infection and activates human hepatic stellate cells.

artículo científico publicado en 2013

Molecular characteristics and successful management of a respiratory syncytial virus outbreak among pediatric patients with hemato-oncological disease.

artículo científico publicado en 2018

Mutagenic Effects of Ribavirin on Hepatitis E Virus-Viral Extinction versus Selection of Fitness-Enhancing Mutations

artículo científico publicado en 2016

Natural reservoirs for homologs of hepatitis C virus.

artículo científico publicado en 2014

Naturally occurring antibodies that recognize linear epitopes in the amino terminus of the hepatitis C virus E2 protein confer noninterfering, additive neutralization

artículo científico publicado en 2012

Non-macrophage-tropic human immunodeficiency virus type 1 R5 envelopes predominate in blood, lymph nodes, and semen: implications for transmission and pathogenesis.

artículo científico publicado en 2006

Recombinant human L-ficolin directly neutralizes hepatitis C virus entry.

artículo científico publicado en 2014

Targeting a host-cell entry factor barricades antiviral-resistant HCV variants from on-therapy breakthrough in human-liver mice

artículo científico publicado en 2015

Tracking HCV protease population diversity during transmission and susceptibility of founder populations to antiviral therapy.

artículo científico publicado en 2017

Variation in HIV-1 R5 macrophage-tropism correlates with sensitivity to reagents that block envelope: CD4 interactions but not with sensitivity to other entry inhibitors.

artículo científico publicado en 2008

Variation in the biological properties of HIV-1 R5 envelopes: implications of envelope structure, transmission and pathogenesis

artículo científico publicado en 2010

Vertical transmission of hepatitis C virus-like non-primate hepacivirus in horses

artículo científico publicado en 2016

Yellow Fever: Integrating Current Knowledge with Technological Innovations to Identify Strategies for Controlling a Re-Emerging Virus

artículo científico publicado en 2019

Lista de obras de Richard Brown

A Diverse Panel of Hepatitis C Virus Glycoproteins for Use in Vaccine Research Reveals Extremes of Monoclonal Antibody Neutralization Resistance.

A case of hepatitis C virus transmission acquired through sharing a haemodialysis machine.

A central hydrophobic E1 region controls the pH range of hepatitis C virus membrane fusion and susceptibility to fusion inhibitors

Acute hepatitis C virus infection: a dynamic-and challenging-concept.

An alpaca nanobody inhibits hepatitis C virus entry and cell-to-cell transmission

Analysis of serine codon conservation reveals diverse phenotypic constraints on hepatitis C virus glycoprotein evolution

Cell entry, efficient RNA replication, and production of infectious hepatitis C virus progeny in mouse liver-derived cells.

Characterization of hepatitis C virus intra- and intergenotypic chimeras reveals a role of the glycoproteins in virus envelopment

Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33.

Clinical course of infection and viral tissue tropism of hepatitis C virus-like nonprimate hepaciviruses in horses

Determination of the human antibody response to the epitope defined by the hepatitis C virus-neutralizing monoclonal antibody AP33.

Development of a high-throughput pyrosequencing assay for monitoring temporal evolution and resistance associated variant emergence in the Hepatitis C virus protease coding-region.

Efficient acute and chronic infection of stem cell-derived hepatocytes by hepatitis C virus

Evolutionary dynamics of hepatitis C virus envelope genes during chronic infection.

Exacerbation of hepatitis E virus infection during anti-TNFα treatment

Flunarizine prevents hepatitis C virus membrane fusion in a genotype-dependent manner by targeting the potential fusion peptide within E1.

Functional and immunogenic characterization of diverse HCV glycoprotein E2 variants

Genetic Diversity Underlying the Envelope Glycoproteins of Hepatitis C Virus: Structural and Functional Consequences and the Implications for Vaccine Design

Hepacivirus NS3/4A Proteases Interfere with MAVS Signaling in both Their Cognate Animal Hosts and Humans: Implications for Zoonotic Transmission

Hepatitis C Virus

Hepatitis C Virus Strain-Dependent Usage of Apolipoprotein E Modulates Assembly Efficiency and Specific Infectivity of Secreted Virions.

Hepatitis C patient-derived glycoproteins exhibit marked differences in susceptibility to serum neutralizing antibodies: genetic subtype defines antigenic but not neutralization serotype.

Hepatitis C virus envelope glycoprotein fitness defines virus population composition following transmission to a new host

Hepatitis E Virus (HEV) ORF2 Antigen Levels Differentiate Between Acute and Chronic HEV Infection

Identification of Conserved Residues in the E2 Envelope Glycoprotein of the Hepatitis C Virus That Are Critical for CD81 Binding

Identification of Keratin 23 as a Hepatitis C Virus-Induced Host Factor in the Human Liver

Immune protection against reinfection with nonprimate hepacivirus.

Immunization with a synthetic consensus hepatitis C virus E2 glycoprotein ectodomain elicits virus-neutralizing antibodies

In vivo evidence for ribavirin-induced mutagenesis of the hepatitis E virus genome

Incorporation of primary patient-derived glycoproteins into authentic infectious hepatitis C virus particles.

Intercompartmental recombination of HIV-1 contributes to env intrahost diversity and modulates viral tropism and sensitivity to entry inhibitors

Ion Channel Function and Cross-Species Determinants in Viral Assembly of Nonprimate Hepacivirus p7 ⬇️

Liver-expressed Cd302 and Cr1l limit hepatitis C virus cross-species transmission to mice

Mannan binding lectin-associated serine protease 1 is induced by hepatitis C virus infection and activates human hepatic stellate cells.

Molecular characteristics and successful management of a respiratory syncytial virus outbreak among pediatric patients with hemato-oncological disease.

Mutagenic Effects of Ribavirin on Hepatitis E Virus-Viral Extinction versus Selection of Fitness-Enhancing Mutations

Natural reservoirs for homologs of hepatitis C virus.

Naturally occurring antibodies that recognize linear epitopes in the amino terminus of the hepatitis C virus E2 protein confer noninterfering, additive neutralization

Non-macrophage-tropic human immunodeficiency virus type 1 R5 envelopes predominate in blood, lymph nodes, and semen: implications for transmission and pathogenesis.

Recombinant human L-ficolin directly neutralizes hepatitis C virus entry.

Targeting a host-cell entry factor barricades antiviral-resistant HCV variants from on-therapy breakthrough in human-liver mice

Tracking HCV protease population diversity during transmission and susceptibility of founder populations to antiviral therapy.

Variation in HIV-1 R5 macrophage-tropism correlates with sensitivity to reagents that block envelope: CD4 interactions but not with sensitivity to other entry inhibitors.

Variation in the biological properties of HIV-1 R5 envelopes: implications of envelope structure, transmission and pathogenesis

Vertical transmission of hepatitis C virus-like non-primate hepacivirus in horses

Yellow Fever: Integrating Current Knowledge with Technological Innovations to Identify Strategies for Controlling a Re-Emerging Virus